209 related articles for article (PubMed ID: 36057322)
1. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Harada T; Ota I; Kitawaki J; Momoeda M; Maeda N; Akira S; Umeyama M; Sunaya T; Hirano K
Contraception; 2022 Dec; 116():22-28. PubMed ID: 36057322
[TBL] [Abstract][Full Text] [Related]
2. Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI).
Kitawaki J; Akira S; Harada T; Maeda N; Momoeda M; Ota I; Murakami T; Sunaya T; Hirano K
Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):300-307. PubMed ID: 35611632
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting.
Momoeda M; Akira S; Harada T; Kitawaki J; Maeda N; Ota I; Yoshihara K; Takahashi N
Adv Ther; 2022 Aug; 39(8):3616-3634. PubMed ID: 35705788
[TBL] [Abstract][Full Text] [Related]
4. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
7. Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.
Yang H; Wang S; Fu X; Lan R; Gong H
J Obstet Gynaecol Res; 2022 Jan; 48(1):161-168. PubMed ID: 34672405
[TBL] [Abstract][Full Text] [Related]
8. Factors Predicting Removals of the Levonorgestrel-Releasing Intrauterine System in an Adolescent Cohort.
Baum A; Chan K; Sachedina A; Grover SR
J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):171-176. PubMed ID: 38128876
[TBL] [Abstract][Full Text] [Related]
9. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
10. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
11. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
12. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
13. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
14. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
15. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E; Wildemeersch P
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
[TBL] [Abstract][Full Text] [Related]
16. Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Magalhaes J; Ferreira-Filho ES; Soares-Junior JM; Baracat EC
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():56-62. PubMed ID: 35809459
[TBL] [Abstract][Full Text] [Related]
17. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
18. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
20. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
